Cargando…
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
Patients with plasma cell dyscrasias (PCDs) experience an increased burden of influenza, and current practice of single-dose annual influenza vaccination yields suboptimal protective immunity in these patients. Strategies to improve immunity to influenza in these patients are clearly needed. We perf...
Autores principales: | Branagan, Andrew R., Duffy, Eamon, Gan, Geliang, Li, Fangyong, Foster, Connor, Verma, Rakesh, Zhang, Lin, Parker, Terri L., Seropian, Stuart, Cooper, Dennis L., Brandt, Debra, Kortmansky, Jeremy, Witt, Davit, Ferencz, Thomas M., Dhodapkar, Kavita M., Dhodapkar, Madhav V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948269/ https://www.ncbi.nlm.nih.gov/pubmed/33683337 http://dx.doi.org/10.1182/bloodadvances.2020003880 |
Ejemplares similares
-
2168: Lower rates of influenza infection following 2 dose series of high-dose vaccination in plasma cell disorders: Results of a randomized, double-blind, placebo-controlled study
por: Branagan, Andrew, et al.
Publicado: (2018) -
Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019) -
Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
por: McCachren, Samuel S., et al.
Publicado: (2021) -
Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
por: Dhodapkar, Kavita M., et al.
Publicado: (2002) -
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)